AquaBounty Technologies Croissance future

Future contrôle des critères 1/6

AquaBounty Technologies devrait augmenter ses bénéfices et ses revenus de 105.9% et de 11.9% par an respectivement, tandis que le BPA devrait croître de croître de 107.7% par an.

Informations clés

105.9%

Taux de croissance des bénéfices

107.7%

Taux de croissance du BPA

Biotechs croissance des bénéfices	28.3%
Taux de croissance des recettes	11.9%
Rendement futur des capitaux propres	n/a
Couverture par les analystes	Low
Dernière mise à jour	06 Nov 2024

Mises à jour récentes de la croissance future

Recent updates

AquaBounty Technologies' First Genetically Engineered Salmon On The Plate - Should You Join The Stream?

Jun 02

Here's Why AquaBounty Technologies (NASDAQ:AQB) Can Manage Its Debt Despite Losing Money

May 09

AquaBounty Technologies: Teach A Man To Fish And You Will Feed Him For A Lifetime

May 03

What Kind Of Shareholders Hold The Majority In AquaBounty Technologies, Inc.'s (NASDAQ:AQB) Shares?

Feb 10

Aquabounty Technologies launches stock offering; stock down ~5% after hours

Feb 03

Richard Huber Is The Independent Non-Executive Director of AquaBounty Technologies, Inc. (NASDAQ:AQB) And They Just Picked Up 16% More Shares

Dec 20

AquaBounty Technologies proposes public offering

Dec 09

Prévisions de croissance des bénéfices et des revenus

NasdaqCM:AQB - Estimations futures des analystes et données financières antérieures (USD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
12/31/2025	1	-9	N/A	N/A	1
12/31/2024	1	-68	N/A	N/A	1
9/30/2024	1	-74	-24	-18	N/A
6/30/2024	2	-76	-45	-21	N/A
3/31/2024	3	-32	-70	-22	N/A
12/31/2023	2	-28	-93	-24	N/A
9/30/2023	2	-25	-110	-22	N/A
6/30/2023	2	-25	-106	-22	N/A
3/31/2023	3	-24	-106	-22	N/A
12/31/2022	3	-22	-88	-21	N/A
9/30/2022	3	-22	-70	-23	N/A
6/30/2022	3	-24	-55	-21	N/A
3/31/2022	2	-23	-32	-21	N/A
12/31/2021	1	-22	-26	-20	N/A
9/30/2021	1	-22	-25	-19	N/A
6/30/2021	0	-19	-23	-18	N/A
3/31/2021	0	-17	-21	-16	N/A
12/31/2020	0	-16	-19	-14	N/A
9/30/2020	0	-14	-17	-14	N/A
6/30/2020	0	-13	-16	-13	N/A
3/31/2020	0	-14	-15	-12	N/A
12/31/2019	0	-13	-14	-11	N/A
9/30/2019	0	-14	-13	-11	N/A
6/30/2019	0	-14	-12	-10	N/A
3/31/2019	0	-13	-12	-9	N/A
12/31/2018	0	-12	-14	-10	N/A
9/30/2018	0	-11	-15	-10	N/A
6/30/2018	0	-10	N/A	-10	N/A
3/31/2018	0	-10	N/A	-9	N/A
12/31/2017	0	-9	N/A	-9	N/A
9/30/2017	0	-9	N/A	-9	N/A
6/30/2017	0	-9	N/A	-8	N/A
3/31/2017	N/A	-9	N/A	-8	N/A
12/31/2016	N/A	-8	N/A	-7	N/A
9/30/2016	N/A	-8	N/A	-7	N/A
6/30/2016	N/A	-7	N/A	-7	N/A
3/31/2016	N/A	-7	N/A	-7	N/A
12/31/2015	N/A	-7	N/A	-7	N/A
9/30/2015	N/A	-7	N/A	-7	N/A
6/30/2015	N/A	-7	N/A	-7	N/A
3/31/2015	N/A	-7	N/A	-7	N/A
12/31/2014	N/A	-7	N/A	-7	N/A
9/30/2014	N/A	-7	N/A	-6	N/A
6/30/2014	N/A	-6	N/A	-5	N/A
3/31/2014	N/A	-5	N/A	-5	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: AQB devrait rester non rentable au cours des 3 prochaines années.

Bénéfices vs marché: AQB devrait rester non rentable au cours des 3 prochaines années.

Croissance élevée des bénéfices: AQB devrait rester non rentable au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de AQB ( 11.9% par an) devrait croître plus rapidement que le marché US ( 8.9% par an).

Croissance élevée des revenus: Le chiffre d'affaires de AQB ( 11.9% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de AQB devrait être élevé dans 3 ans

AquaBounty Technologies Croissance future

Future contrôle des critères 1/6

Informations clés

Mises à jour récentes de la croissance future

Consensus revenue estimates fall by 45%

Consensus revenue estimates fall by 67%

Consensus revenue estimates increase by 10%

Consensus revenue estimates decrease by 20%

Consensus revenue estimates fall by 33%

Price target decreased to US$4.00

Recent updates

Third quarter 2024 earnings: EPS in line with expectations, revenues disappoint

New minor risk - Share price stability

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

AquaBounty Technologies, Inc. Announces CEO Changes

AquaBounty Technologies, Inc. Announces CEO Changes

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Consensus revenue estimates fall by 45%

AquaBounty Technologies, Inc., Annual General Meeting, May 23, 2024

Consensus revenue estimates fall by 67%

Full year 2023 earnings: EPS and revenues miss analyst expectations

New minor risk - Shareholder dilution

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

New major risk - Share price stability

New major risk - Market cap size

AquaBounty Technologies, Inc. Announces Board Changes

New minor risk - Share price stability

Consensus revenue estimates increase by 10%

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus revenue estimates decrease by 20%

Consensus revenue estimates fall by 33%

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Full year 2022 earnings: EPS in line with expectations, revenues disappoint

Director recently bought US$101k worth of stock

Price target decreased to US$4.00

High number of new directors

Price target decreased to US$4.00

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

AquaBounty Technologies Receives Non-Compliance Notice from Nasdaq

AquaBounty: Not Casting A Lure Yet

Consensus forecasts updated

High number of new directors

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

AquaBounty Technologies GAAP EPS of -$0.08, revenue of $1.07M

AquaBounty Technologies, Inc., Annual General Meeting, May 27, 2022

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target decreased to US$5.88

Consensus revenue estimates fall by 22%

AquaBounty CEO Sylvia Wulf - Genetically Modified Sustainable Salmon

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Third quarter 2021 earnings released: US$0.097 loss per share (vs US$0.094 loss in 3Q 2020)

Price target decreased to US$8.33

Second quarter 2021 earnings released: US$0.074 loss per share (vs US$0.11 loss in 2Q 2020)

Aquabounty Technologies, Inc. Receives Approval for the Sale of GE Atlantic Salmon in Brazil

Independent Non-Executive Director has left the company

AquaBounty Technologies' First Genetically Engineered Salmon On The Plate - Should You Join The Stream?

Consensus forecasts updated

Here's Why AquaBounty Technologies (NASDAQ:AQB) Can Manage Its Debt Despite Losing Money

First quarter 2021 earnings released: US$0.064 loss per share (vs US$0.12 loss in 1Q 2020)

AquaBounty Technologies: Teach A Man To Fish And You Will Feed Him For A Lifetime

Earnings beat expectations, revenue disappoints

New 90-day low: US$6.09

Analysts update estimates

AquaBounty Technologies, Inc. Elects Ricardo J. Alvarez as A Non-Executive Director

What Kind Of Shareholders Hold The Majority In AquaBounty Technologies, Inc.'s (NASDAQ:AQB) Shares?

AquaBounty Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $110.5 million.

Aquabounty Technologies launches stock offering; stock down ~5% after hours

New 90-day high: US$10.34

New 90-day high: US$9.74

Richard Huber Is The Independent Non-Executive Director of AquaBounty Technologies, Inc. (NASDAQ:AQB) And They Just Picked Up 16% More Shares

Analysts update estimates

AquaBounty Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $56.68 million.

AquaBounty Technologies proposes public offering

New 90-day high: US$5.80

Analysts lower revenue estimates to US$657.3k

Price target raised to US$4.83

Earnings beat expectations, revenue disappoints

New 90-day high: US$4.50

AquaBounty Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $27.5 million.

Earnings released